Welcome To ChemAnalyst
The market for Dimethylamine (DMA) in India is showing a moderate uptick in the first half of November 2025, due to suppliers effectively managing the production process along with steady demand in key end-use markets such as pharmaceutical, agrochemical, and specialty chemicals.
In India, DMA supply is adequately managed as the combined capacity is just over xxx,xxx tons of leading producers AACL, Balaji, RCF and Aarti Drug. AACL continues at a high run-rate with good volumes still available to the market after accounting for internal use. Aarti drugs have just commissioned a new capacity of xx – xxktpa and is slowly ramping up to add to the overall supply. Alkyl Amine saw an increase in revenue of xx YoY at INR xxx crore compared to INR xxx crore in the previous year. Balaji amines reported a total sales volume for the quarter in question of xx,xxx metric tonnes including: amines at x,xxx MT, amine derivatives at x,xxx MT, and speciality chemicals at xx,xxx MT. The company reported that margins benefited from both a better product mix as well as cost savings despite weakness in the pharmaceutical value chain, and export...
We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.
